MedTrace Logo

Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers

NCT00564447 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2011-09-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the drug concentrations of AzaSite™ compared to Vigamox at various time points in conjunctiva tissue of healthy volunteers

Conditions

Interventions

DRUG

Azithromycin

azithromycin topical solution 1% given as a single drop in a single eye

DRUG

Moxifloxacin

Moxifloxacin topical solution given as a single drop in a single eye

Sponsors & Collaborators

Principal Investigators

  • Reza Haque · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2007-12-31

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00564447 on ClinicalTrials.gov